Admissibility of DBS Technology for AOD Detection in Probation Proceedings

This paper explores the admissibility of Dried Blood Spot (DBS) technology for Alcohol and Other Drug (AOD) testing in probation violation proceedings, highlighting OpAns’ patented amasse™ collection device. Utilizing DBS technology, this minimally invasive method provides advantages like easy sample collection, extended detection windows, and broader substance analysis.

DBS testing has emerged as a superior alternative to urine testing due to its longer detection periods, room-temperature transport stability, and tamper-proof process. This makes DBS particularly valuable in resource-limited areas for effective AOD detection.

In court proceedings, the admissibility of evidence such as DBS testing is determined by the Daubert Standard or the Frye Standard, depending on the jurisdiction. The amasse™ device meets the criteria of both, ensuring its reliability and accuracy in legal contexts.

Backed by liquid chromatography–mass spectrometry technology and validated in peer-reviewed research, the amasse™ DBS system delivers precise and court-admissible results. Its adoption in probation settings improves supervision through a more efficient, data-driven, and privacy-respecting approach, offering significant benefits for justice professionals and probationers alike.